StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.22−0.02 (-6.64%)

Close on Nov 12, 2026Market cap $534.85KP/E –Yield –

Arcadia Biosciences, Inc. saw revenue fall 2.1% to $5.06M over the twelve months to Sep 30, 2026. Free cash flow was -$4.70M. At the latest close the market valued the company at $534.85K.

Revenue
$5.06M
-2.1% vs. a year earlier
Operating income
-$3.49M
TTM Q3 2026
Free cash flow
-$4.70M
FY2025
EPS, diluted
-$4.88
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$534.85K
P/E ratio
–
Price to sales
0.11
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$5.06M
Net income
-$10.23M
EPS, diluted
-$4.88
Free cash flow
-$4.70M
Diluted shares
6M

Trading

Next earnings
Q3 FY2026, expected soon
Previous close
$0.24
Open
$0.18
Day's range
$0.18 – $0.23
Volume
2,615,105
Average volume (20 days)
1,638,839
Beta (5 years)
1.04
52-week range
$0.11 – $3.87
RSI (14 days)
53.8
Volatility (1 year)
102.9%
Relative volume
1.58×
WACC
10.1%

Market cap history

Month-end market cap since 2015, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodRKDAS&P 500DifferenceRKDA per yearS&P 500 per year
1 month-1.8%-2.7%+0.9 pts
3 months-68.3%-1.7%−66.5 pts
Year to date-88.8%+11.9%−100.7 pts
1 year-93.8%+12.0%−105.8 pts
3 years-92.9%+78.2%−171.1 pts-58.6%+21.2%
5 years-99.7%+73.2%−173.0 pts-69.1%+11.6%
10 years-100.0%+309.6%−409.6 pts-56.9%+15.1%

Thirteen years at a glance

Fiscal years 2013 to 2025 and trailing twelve months, USD

Revenue

$5.06M-2.1% YoY

Gross profit

$2.08M+6.4% YoY

Operating income

-$3.49M

Net income

-$10.23M

EPS, diluted

-$4.88

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases Arcadia Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Arcadia Biosciences

Beverages

Arcadia Biosciences develops and sells consumer beverage products focused on health and wellness. The company’s core offering is its Zola coconut water line, which provides hydration across several flavors including original, pulp, espresso, and pineapple. Previously focused on agricultural biotechnology, crop traits, and wheat products, the business has divested its historical wheat traits, patent rights, and food brands to concentrate on its beverage operations. Arcadia distributes its beverages primarily to grocery retailers and foodservice distributors across the market.

Company profile, executives and history

Arcadia Biosciences stock: common questions

What is Arcadia Biosciences's stock price?

RKDA closed at $0.22 on Nov 12, 2026, down 6.64% on the day. Over the past 52 weeks it traded between $0.11 and $3.87.

What is Arcadia Biosciences's market cap?

Arcadia Biosciences was worth $534.85K at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is RKDA's P/E ratio?

Arcadia Biosciences lost money over the twelve months to Sep 30, 2026 (diluted EPS -$4.88), so it has no meaningful P/E ratio.

How much revenue does Arcadia Biosciences make?

Arcadia Biosciences reported revenue of $5.06M for the twelve months to Sep 30, 2026, down 2.1% from a year earlier.

Does Arcadia Biosciences pay a dividend?

No. Arcadia Biosciences has not paid a cash dividend over the last twelve months.

When does Arcadia Biosciences report earnings next?

Arcadia Biosciences's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.

How has RKDA stock performed over the past year?

Including dividends, RKDA returned -93.8% over the past year, against +12.0% for the S&P 500.

How many RKDA shares are sold short?

0M shares were sold short at the latest FINRA report, 4.87% of the float, or 1.0 days of average trading volume.

Who are Arcadia Biosciences's competitors?

Companies most similar to Arcadia Biosciences by business, industry and size include AGIG, SPND, MXC, EONR, VGTK.

See a number that looks wrong?